Bill > A01522

This bill amends the New York mental hygiene law to require the Office of Addiction Services and Supports (OASAS) to actively encourage, support, and facilitate clinical research specifically focused on ibogaine as a potential treatment for addiction to heroin, methamphetamine, and cocaine. Ibogaine is a naturally occurring psychoactive substance derived from the iboga plant, which has shown potential in some preliminary studies for interrupting addictive behaviors, though it remains a controlled substance with limited research. The legislation aims to promote scientific investigation into ibogaine's therapeutic potential by mandating that OASAS take a proactive role in supporting and advancing clinical research in this area. By specifically naming three highly problematic and challenging drug addictions, the bill underscores the urgent need to explore alternative and innovative approaches to addiction treatment. The bill would take effect immediately upon passage, signaling the state's commitment to addressing substance use disorders through innovative research strategies.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A1522